Find drug development pipeline and deal Updates information

Lead Product(s): ChAdOx1

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Phase I Product Type: Vaccine

Partner/Sponsor/Collaborator: The Jenner Institute, Oxford University

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement February 11, 2020

Details:

The Jenner Institute at the University of Oxford has agreed a contract with Advent Srl, to produce the first batch of the novel coronavirus vaccine ChAdOx1 nCoV-19 for clinical testing.